COVID-19 vaccine - Cobra Biologics
Latest Information Update: 28 Apr 2024
At a glance
- Originator Cobra Biologics
- Class COVID-19 vaccines; DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for research development in COVID-2019-infections in United Kingdom (IM)
- 30 Mar 2020 Early research in COVID-2019 infections in United Kingdom (IM) before March 2020
- 30 Mar 2020 Cobra Biologics plans a phase I trial for COVID-2019 infections in Sweden in 2021